Bio
Dr. Bhaskar Chaudhuri joined Frazier Healthcare as an Operating Partner in 2011. Previously, Dr. Chaudhuri served as the President, Valeant Pharmaceuticals International through the end of 2010. He joined Valeant through the Company’s acquisition of Dow Pharmaceutical Sciences, Inc. in late 2008 where Dr. Chaudhuri served as President and Chief Executive Officer. Before joining Dow, Dr. Chaudhuri worked at Mylan Pharmaceuticals in different capacities including Executive Vice President of Scientific Affairs (Bertek Pharmaceuticals, a subsidiary of Mylan Laboratories) and as the General Manager of the Dermatology Division of Mylan Laboratories. Dr. Chaudhuri joined Mylan through the acquisition of Penederm Inc., where he was the Vice President of Research and Development. Dr. Chaudhuri has over 20 years of experience in pharmaceutical management and currently also serves on the Board of two companies. He holds a Doctorate in Physical Pharmacy, a Master of Science in Industrial Pharmacy and a Bachelors of Science in Pharmacy.
Career
|
Frazier Healthcare VenturesInvestment firm providing growth and venture capital to healthcare companies. |